Audioboom logo
Menu
Audioboom logo
  • Podcasts
  • Advertisers
  • Creators
  • Help & support
  • Sign up
  • Sign in
Podcasts
Advertisers
Creators
Help & support
Search podcasts
Sign up
Sign in
Podcast logo
Not So Different: A Podcast from The Center for Biosimilars

The Top 5 Most-Listened to Podcasts of 2024

Season 6, Episode 41,   Dec 29, 2024, 03:00 PM

Headliner
See more options
Share
Facebook X
Subscribe

On this episode of Not So Different, we reflect on 2024 and this show in particular, taking audiences back through the most popular podcast episodes of the year.

Here are the top 5 episodes of Not So Different from 2024.

Number 5: Breaking Barriers in Osteoporosis Care: New Denosumab Biosimilars Wyost, Jubbonti Approved
Number 4: Decoding the Patent Puzzle: Navigating the Legal Landscape of Biosimilars
Number 3:
Insights from Festival of Biologics: Dracey Poore Discusses Cardinal Health’s 2024 Biosimilar Report
Number 2:
Biosimilars in America: Overcoming Barriers and Maximizing Impact
Number 1:
Exploring the Biosimilar Horizon: Julie Reed's Predictions for 2024
Share
Facebook X
Subscribe
Next
Biosimilars in Action: Market Shifts, Legal Insights, and FDA Approvals
Top episodes
Dr. Sang-Jin Pak Talks Biosimilar Markets: US vs Europe
by Not So Different: A Podcast from The Center for Biosimilars
Dr Sang-Jin Pak Talks Biosimilar Market Stability
by Not So Different: A Podcast from The Center for Biosimilars
Ryan Haumschild, PharmD, Discusses Plan to Increase Biosimilar Utilization
by Not So Different: A Podcast from The Center for Biosimilars
  •   Report this episode
  •   Download audio
  •   QRCode
For podcasters For advertisers For listeners
Help & feedback About us Blog Investor relations
Cookie policy Privacy policy Terms & conditions
©2025 Audioboom

Sorry, your browser isn't supported.

We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.

Page load failed

Please check your internet connection and refresh the page. You might also try disabling any ad blockers.

You can visit our support center if you're having problems.